Automated sample preparation using the Biotage® Extrahera™ was compared to an equivalent manual method utilizing a vacuum manifold. A selection of non-steroidal anti-inflammatory drugs (NSAIDS) were extracted from pooled stripped plasma using a supported liquid extraction procedure. ISOLUTE® SLE+ 400 µL sample volume plates, part number 820-0400-P01 were used for extraction.
Resulting extracts from both sample preparation methods were subsequently analysed by LC-MS/MS.
A pooled plasma sample was prepared in a sufficient quantity to run a full 96-well plate for each processing method. This pooled plasma sample was fortified with Sulindac, Ketoprofen and Indomethacin at a concentration of 25 ng/mL respectively.
From this pooled plasma sample 250 µL was transferred to all wells of two 96-well plates.
All subsequent aspects of sample preparation were performed in duplicate on two separate plates utilizing either Extrahera™ or manual preparation using a calibrated air-displacement pipette.
The pooled plasma sample was pre-treated 1:1 (v/v) with 1 % formic acid (250 µL). This sample dilution results in approximate loading pH of 3.2.
After pre-wetting the pipette tips via aspirate/dispense cycling and to mix the samples; 400 µL of the pre-treated sample was loaded to each well of the ISOLUTE® SLE+ plates. Flows were initiated using a pulse of positive pressure (Extrahera™) or vacuum (manual method).
After leaving for 5 minutes to allow the sample to completely absorb into the plates, elution was performed by the application of 2 x 0.9 mL aliquots of methyl tertiary-butyl ether (MTBE) to the ISOLUTE® SLE+ plates. The extracts were collected in 2 mL 96-well collection plates under gravity elution, and as a final step to recover all available solvent from the media, by applying a pulse of positive pressure (Extrahera™) or vacuum (manual method). The extracts were evaporated to dryness in a TurboVap® 96 at 37 °C and reconstituted in 200 µL of 60:40 (v/v) water/methanol solution. The plates were mixed on an orbital shaker for 10 minutes.
Instrument: Waters Alliance 2795
Cartridge: ACE Excel 2 C18-AR 50 x 2.1mm id cartridge
Mobile Phase: 50:50 (v/v) 0.1 % (v/v) formic acid/acetonitrile at 0.25 mL/min
Injection Volume: 25 µL
Instrument: Waters Quattro Ultima Pt
MRM Conditions
|
Analyte |
Transition |
RT (min) |
Dwell (sec) |
Cone (V) |
Col Energy (V) |
|
Indomethacin |
358.1 to 139.0 |
2.5 |
0.1 |
35 |
18 |
|
Sulindac |
357.1 to 233.1 |
0.9 |
0.1 |
35 |
26 |
|
Ketoprofen |
255.1 to 209.1 |
1.2 |
0.1 |
35 |
13 |
Average peak area data was calculated for all three compounds to compare any improvements in analyte recovery between Biotage® Extrahera™ and manually processed samples.
Peak area ratio data was also generated for all samples by referencing the analyte vs. Ketoprofen. This provides standardized data to allow a comparison of the % RSD of the Extrahera vs. manual data sets.
|
|
Extrahera Sulindac Peak Area Ratio Summary |
Manual Sulindac Peak Area Ratio Summary |
|
Average Sulindac Peak Area |
24622 |
22847 |
|
Improvement (%) vs. Manual Method |
7.8 |
- |
|
|
|
|
|
Average IS Peak Area |
35199 |
32683 |
|
Improvement (%) vs. Manual Method |
7.7 |
- |
|
|
|
|
|
Average Peak Area Ratio |
0.701 |
0.705 |
|
% RSD of Extrahera™ Extraction |
4.01 |
6.43 |
|
Improvement (%) vs. Manual Method |
37.6 |
- |
|
|
|
|
|
|
Extrahera Indomethacin Peak Area Ratio Summary |
Manual Indomethacin Peak Area Ratio Summary |
|
Average Indomethacin Peak Area |
34395 |
27965 |
|
Improvement (%) vs. Manual Method |
23.0 |
- |
|
|
|
|
|
Average IS Peak Area |
35199 |
32683 |
|
Improvement (%) vs. Manual Method |
7.7 |
- |
|
|
|
|
|
Average Peak Area Ratio |
0.977 |
0.857 |
|
% RSD of Extrahera™ Extraction |
5.46 |
8.56 |
|
Improvement (%) vs. Manual Method |
36.2 |
- |
A significant reduction to the % RSD was measured when using the Biotage® Extrahera™ for both compounds compared to the manual processing approach.
|
% RSD |
Manual Procedure (n=96) |
Extrahera (n=96) |
|
Sulindac |
6.43 |
4.01 |
|
Indomethacin |
8.56 |
5.46 |
For Sulindac the % RSD improved by 37%, for Indomethacin there was also an improvement in the % RSD by 36 % to 5.46%. The results also suggest that methods performed on the Extrahera™ could give higher recoveries due to increases in the absolute average peak areas
|
|
Manual Procedure (n=96) |
Extrahera (n=96) |
|
Sulindac |
22847 |
24622 |
|
Indomethacin |
27965 |
34395 |
Both compounds returned average peak areas that were higher when sample extraction was performed using Extrahera™ than the manual method with an average peak area increase of 15.4%. The greatest improvement was measured with Indomethacin where the average peak area was increased by 23%.
Literature number: PPS361